section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
44/2002<br />
31 Oct/oct 2002 PCT Gazette - Section I - Gazette du PCT 21729<br />
(51) 7 C07D 233/54, A61K 7/48, A61P 17/00,<br />
C07D 403/06<br />
(11) WO 02/085864 (13) A1<br />
(21) PCT/FR02/01413<br />
(22) 24 Apr/avr 2002 (24.04.2002)<br />
(25) fr (26) fr<br />
(30) 01/05498 24 Apr/avr 2001 FR<br />
(24.04.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) COMPOUNDS OF THE FAMILY OF<br />
3-ALKYL-(4,5 DIPHENY-IMIDA-<br />
ZOL-1-YL) AND THEIR USE AS<br />
SOOTHING AGENTS<br />
COMPOSES DE LA FAMILLE DES<br />
3-ALKYL-(4,5 DIPHENYL-IMIDA-<br />
ZOL-1-YL) ET LEUR UTILISATION<br />
COMME APAISANTS<br />
(71) L’OREAL [FR/FR]; 14, rue Royale,<br />
F-75008 Paris (FR).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) GALEY, Jean-Baptiste [FR/FR];<br />
12, rue Charles-Dordain, F-93600<br />
Aulnay-sous-Bois (FR). MAHE, Yann<br />
[FR/FR]; 36, avenue de l’Epargne, F-91390<br />
Morsang-sur-Orge (FR). DALKO, Maria<br />
[FR/FR]; 16, Résidence du Château de<br />
Courcelles, F-91190 Gif sur Yvette (FR).<br />
DUMATS, Jacqueline [FR/FR]; 13, rue<br />
Ambroise Croizat, F-93420 Villepinte (FR).<br />
(74) ALLAB, Myriam; L’Oréal - DPI, 6, rue<br />
Bertrand Sincholle, F-92585 Clichy Cedex<br />
(FR).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG US UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(51) 7 C07D 235/06, 285/12, 263/20<br />
(11) WO 02/085865<br />
(21) PCT/US02/08262<br />
(13) A1<br />
(22) 15 Apr/avr 2002 (15.04.2002)<br />
(25) en (26) en<br />
(30) 60/285,588 20 Apr/avr 2001<br />
(20.04.2001)<br />
US<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) A METHOD FOR THE PREPARATION<br />
OF OXAZOLIDINONES<br />
PROCEDE DE PREPARATION D’OXA-<br />
ZOLIDINONES<br />
(71) PHARMACIA & UPJOHN COMPANY<br />
[US/US]; 301 Henrietta Street, Kalamazoo,<br />
MI 49001 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) CHEN, Jiong, Jack [CN/US]; 6725<br />
Bayridge Road, Kalamazoo, MI 49009 (US).<br />
LU, Cuong, V. [US/US]; 3811 Dale Street,<br />
Kalamazoo, MI 49001 (US).<br />
(74) NESBITT, Stephen, L.; Pharmacia & Upjohn<br />
Company, Global <strong>Intellectual</strong> <strong>Property</strong>,<br />
301 Henrietta Street, Kalamazoo, MI 49001<br />
(US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG US UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(51) 7 C07D 239/06, A61K 31/4184<br />
(11) WO 02/085866 (13) A1<br />
(21) PCT/SE02/00769<br />
(22) 18 Apr/avr 2002 (18.04.2002)<br />
(25) en (26) en<br />
(30) 0101387-9 20 Apr/avr 2001 SE<br />
(20.04.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) NOVEL COMPOUNDS<br />
NOUVEAUX COMPOSES<br />
(71) ASTRAZENECA AB [SE/SE]; S-151 85<br />
Södertälje (SE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) CHENG, Yun-Xing [CA/CA]; AstraZeneca<br />
R & D Montreal, 7171 Frederick-Banting,<br />
St. Laurent, Montreal,<br />
Québec H4S 1Z9 (CA). TOMASZEW SKI,<br />
Miroslaw [CA/CA]; AstraZeneca R & D<br />
Montreal, 7171 Frederick-Banting, St. Laurent,<br />
Montreal, Québec H4S 1Z9 (CA).<br />
WALPOLE, Christopher [GB/CA]; AstraZeneca<br />
R & D Montreal, 7171 Frederick-Banting,<br />
St. Laurent, Montreal, Québec<br />
H4S 1Z9 (CA). YANG, Hua [CA/CA];<br />
AstraZeneca R & D Montreal, 7171 Frederick-Banting,<br />
St. Laurent, Montreal, Québec<br />
H4S 1Z9 (CA).<br />
(74) GLOBAL INTELLECTUAL PROP-<br />
ERTY; AstraZeneca AB, S-151 85 Södertälje<br />
(SE).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG US UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
Declarations / Déclarations :<br />
(s) for the following designations / pour les<br />
désignations suivantes : AE AG AL AM AT AU AZ<br />
BA BB BG BR BY BZ CA CH CN CO CR CU CZ<br />
DE DK DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW MX<br />
MZ NO NZ OM PH PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA<br />
ZMZWAP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW) EA (AM AZ BY KG KZ MD RU TJ<br />
TM) EP (AT BE CH CY DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE TR) OA (BF BJ CF CG<br />
CI CM GA GN GQ GW ML MR NE SN TD TG)<br />
(u) for / pour US only / seulement<br />
(51) 7 C07D 239/08, 239/28, A61K 31/506, A61P<br />
31/04<br />
(11) WO 02/085867 (13) A1<br />
(21) PCT/US02/13024<br />
(22) 25 Apr/avr 2002 (25.04.2002)<br />
(25) en (26) en<br />
(30) 60/286,297 25 Apr/avr 2001 US<br />
(25.04.2001)<br />
(30) 60/290,140 10 May/mai 2001 US<br />
(10.05.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) ANTIBIOTICS AA-896<br />
ANTIBIOTIQUES AA-896<br />
(71) AMERICAN CYANAMID COMPANY<br />
[US/US]; Five Giralda Farms, Madison, NJ<br />
07940 (US).<br />
(72) LIN, Yang-I; 35 Constitution Drive, Tappan,<br />
NY 10983 (US). Li, Zhong; 8 Cygnet Road,<br />
Congers, NY 10920 (US). FRANCISCO,<br />
Gerardo DelaCruz; 23 Henry Street, Orangeburg,<br />
NY 10962 (US). MCDONALD,<br />
Leonard, Alexander; 323 Briar Patch,<br />
Mountainside, NJ 07092 (US).<br />
(74) MORAN, Daniel, B. et al. / etc.; Wyeth,<br />
Patent Law Department, Five Giralda Farms,<br />
Madison, NJ 07940 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RUTJTM);EP(ATBECHCYDEDKES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(51) 7 C07D 265/36, A61K 31/538, A61P 35/00<br />
(11) WO 02/085868<br />
(21) PCT/GB02/01726<br />
(13) A1<br />
(22) 15 Apr/avr 2002 (15.04.2002)<br />
(25) en (26) en<br />
(30) 01401031.8 23 Apr/avr 2001<br />
(23.04.2001)<br />
FR<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) BENZOXAZINONE DERIVATIVES<br />
FOR USE IN THE TREATMENT OF<br />
ANGIOGENESIS<br />
DERIVES DE BENZOXAZINONE<br />
POUR LE TRAITEMENT DE L’AN-<br />
GIOGENESE